Kenporen Director Calls on Pharma Industry, MHLW to Share More Data toward FY2024 Reform

Kenporen Director Masato Matsumoto The pharmaceutical industry and the health ministry should present more detailed data in upcoming discussions toward the FY2024 drug pricing reform, says Masato Matsumoto, representing the payer side of the Central Social Insurance Medical Council (Chuikyo)...read more